Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-08-23

Clinical Trial Update: Safety and Tolerability of Low Dose Primaquine [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating the safety and tolerability of a low-dose primaquine regimen for falciparum malaria, including considerations in individuals wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Primaquine (primaquine)

Snippet

Sponsor: Malaria Consortium | Conditions: Malaria, Falciparum, G6PD Deficiency | Phase 4 | Status: COMPLETED